NCT06319027View on ClinicalTrials.gov

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Glioblastoma, IDH-Wildtype
Interventions
PROCEDURE

Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging

Undergo DSC-MRI

OTHER

Fluciclovine F18

Given IV

DRUG

Gadolinium-Chelate

Receive gadolinium-based contrast agent

PROCEDURE

Magnetic Resonance Spectroscopy

Undergo MR spectroscopy

PROCEDURE

Positron Emission Tomography

Undergo PET scan

Trial Locations (1)

53792

RECRUITING

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK